Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert W Robey

Showing results (61-70 of 122) with videos related to

Pageof 13
Sort By:
Cancers|June 10, 2022
A Histone Deacetylase Inhibitor Induces Acetyl-CoA Depletion Leading to Lethal Metabolic Stress in RAS-Pathway Activated CellsAgnes Basseville, Pierre-Christian Violet, Maryam Safari, et al.
Cancer Chemotherapy and Pharmacology|January 10, 2009
Becatecarin (rebeccamycin analog, NSC 655649) is a transport substrate and induces expression of the ATP-binding cassette transporter, ABCG2, in lung carcinoma cellsRobert W Robey, Tomasz Obrzut, Suneet Shukla, et al.
Cancer Research|July 5, 2012
HG-829 is a potent noncompetitive inhibitor of the ATP-binding cassette multidrug resistance transporter ABCB1Gisela Caceres, Robert W Robey, Lubomir Sokol, et al.
Biorxiv : the Preprint Server for Biology|November 21, 2023
Identification of NanoLuciferase Substrates Transported by Human ABCB1 and ABCG2 and their Zebrafish Homologs at the Blood-Brain BarrierCollin T Inglut, John A Quinlan, Robert W Robey, et al.
Investigative Ophthalmology & Visual Science|September 17, 2021
Dual Inhibition of Histone Deacetylases and the Mechanistic Target of Rapamycin Promotes Apoptosis in Cell Line Models of Uveal MelanomaRuchi P Patel, Joanna R Thomas, Katherine M Curt, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 29, 2010
Comparison of ATP-binding cassette transporter interactions with the tyrosine kinase inhibitors imatinib, nilotinib, and dasatinibMarius Dohse, Christian Scharenberg, Suneet Shukla, et al.
Cancers|October 28, 2023
Novel Therapeutic Strategies Exploiting the Unique Properties of Neuroendocrine NeoplasmsMaryam Safari, Luigi Scotto, Thomas Litman, et al.
Cancer Research|July 23, 2003
Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transportZhe-Sheng Chen, Robert W Robey, Martin G Belinsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Evidence for microtubule target engagement in tumors of patients receiving ixabepiloneSen H Zhuang, Y Elizabeth Hung, Laura Hung, et al.
Pharmacological Reports : PR|November 7, 2006
MDR1 (ABCB1) gene polymorphism C3435T is associated with P-glycoprotein activity in B-cell chronic lymphocytic leukemiaKrzysztof Jamroziak, Ewa Balcerczak, Piotr Smolewski, et al.
Pageof 13

Showing results (61-70 of 122) with videos related to

Sort By:
Pageof 13
Cancers|June 10, 2022
A Histone Deacetylase Inhibitor Induces Acetyl-CoA Depletion Leading to Lethal Metabolic Stress in RAS-Pathway Activated CellsAgnes Basseville, Pierre-Christian Violet, Maryam Safari, et al.
Cancer Chemotherapy and Pharmacology|January 10, 2009
Becatecarin (rebeccamycin analog, NSC 655649) is a transport substrate and induces expression of the ATP-binding cassette transporter, ABCG2, in lung carcinoma cellsRobert W Robey, Tomasz Obrzut, Suneet Shukla, et al.
Cancer Research|July 5, 2012
HG-829 is a potent noncompetitive inhibitor of the ATP-binding cassette multidrug resistance transporter ABCB1Gisela Caceres, Robert W Robey, Lubomir Sokol, et al.
Biorxiv : the Preprint Server for Biology|November 21, 2023
Identification of NanoLuciferase Substrates Transported by Human ABCB1 and ABCG2 and their Zebrafish Homologs at the Blood-Brain BarrierCollin T Inglut, John A Quinlan, Robert W Robey, et al.
Investigative Ophthalmology & Visual Science|September 17, 2021
Dual Inhibition of Histone Deacetylases and the Mechanistic Target of Rapamycin Promotes Apoptosis in Cell Line Models of Uveal MelanomaRuchi P Patel, Joanna R Thomas, Katherine M Curt, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 29, 2010
Comparison of ATP-binding cassette transporter interactions with the tyrosine kinase inhibitors imatinib, nilotinib, and dasatinibMarius Dohse, Christian Scharenberg, Suneet Shukla, et al.
Cancers|October 28, 2023
Novel Therapeutic Strategies Exploiting the Unique Properties of Neuroendocrine NeoplasmsMaryam Safari, Luigi Scotto, Thomas Litman, et al.
Cancer Research|July 23, 2003
Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transportZhe-Sheng Chen, Robert W Robey, Martin G Belinsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Evidence for microtubule target engagement in tumors of patients receiving ixabepiloneSen H Zhuang, Y Elizabeth Hung, Laura Hung, et al.
Pharmacological Reports : PR|November 7, 2006
MDR1 (ABCB1) gene polymorphism C3435T is associated with P-glycoprotein activity in B-cell chronic lymphocytic leukemiaKrzysztof Jamroziak, Ewa Balcerczak, Piotr Smolewski, et al.
Pageof 13